127 related articles for article (PubMed ID: 7161779)
1. Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.
Kallenberg CG; Vellenga E; Wouda AA; The TH
J Rheumatol; 1982; 9(6):878-84. PubMed ID: 7161779
[TBL] [Abstract][Full Text] [Related]
2. [Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma].
Cuenca R; Fernández-Cortijo J; Lima J; Fonollosa V; Simeón CP; Pico M; Soriano B; Vilardell M
Med Clin (Barc); 1990 Dec; 95(20):761-3. PubMed ID: 2151867
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
4. Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.
van der Maulen J; Wouda AA; Mandema E; The TH
Clin Exp Immunol; 1979 Jan; 35(1):62-6. PubMed ID: 428147
[TBL] [Abstract][Full Text] [Related]
5. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
6. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
7. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
8. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
9. Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
Lau CS; McLaren M; Mackay I; Belch JJ
Ann Rheum Dis; 1993 Jun; 52(6):443-8. PubMed ID: 8323396
[TBL] [Abstract][Full Text] [Related]
10. Assessment of platelet function in patients with Raynaud's syndrome.
Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
[TBL] [Abstract][Full Text] [Related]
12. [Vascular function parameters in idiopathic and quartz-induced progressive scleroderma].
Haustein UF; Scheel H; Siegemund A; Krusche U
Hautarzt; 1993 Nov; 44(11):717-22. PubMed ID: 8276590
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon.
Porciello G; Scarpato R; Ferri C; Storino F; Cagetti F; Morozzi G; Bellisai F; Migliore L; Marcolongo R; Galeazzi M
J Rheumatol; 2003 Jun; 30(6):1244-7. PubMed ID: 12784397
[TBL] [Abstract][Full Text] [Related]
14. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
15. Elevated homocysteine levels in patients with Raynaud's syndrome.
Levy Y; George J; Langevitz P; Harats D; Doolman R; Sela BA; Shoenfeld Y
J Rheumatol; 1999 Nov; 26(11):2383-5. PubMed ID: 10555896
[TBL] [Abstract][Full Text] [Related]
16. Immunologic abnormalities in idiopathic Raynaud's phenomenon.
Moutsopoulos HM; Constantopoulos S; Gerber LH; Lawley TJ
Clin Exp Rheumatol; 1983; 1(1):45-8. PubMed ID: 6681124
[TBL] [Abstract][Full Text] [Related]
17. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology.
Hirschl M; Kundi M
J Rheumatol; 1996 Feb; 23(2):302-9. PubMed ID: 8882036
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
[TBL] [Abstract][Full Text] [Related]
19. Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty.
Bunescu A; Widman J; Lenkei R; Menyes P; Levin K; Egberg N
Clin Sci (Lond); 2002 Mar; 102(3):279-86. PubMed ID: 11869168
[TBL] [Abstract][Full Text] [Related]
20. Deficient fibrinolytic response in patients with Raynaud's phenomenon and its correction with defibrotide.
Cimminiello C; Milani M; Pietra A; Rossi F; Aloisio M; Nazzari M; Bonfardeci G
Semin Thromb Hemost; 1991; 17 Suppl 1():106-11. PubMed ID: 2068563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]